Status:
ACTIVE_NOT_RECRUITING
Development of the Italian Version of the ICU Mobility Scale (IMS). Cross-cultural Adaptation, Italian Translation, and Validation Study.
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Muscle Weakness
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Early mobilisation of the patient admitted to intensive care units (ICUs) is essential to prevent Intensive Care Unit Acquired Weakness (ICUAW). It is essential to be able to measure functional mobili...
Eligibility Criteria
Inclusion
- patients aged ≥ 18 years
- ability self-mobility prior to hospital admission (assessed by the Clinical Frailty Scale), if applicable, the reasons for inclusion of vulnerable patients.
Exclusion
- Concurrent admission due to newly diagnosed or suspected neurological disorders (e.g., stroke, intracranial hemorrhages, head trauma, Guillain-Barré syndrome, status epilepticus)
- Primary neurological or myopathic processes associated with muscle weakness (e.g. Guillain-Barré syndrome)
- Inability to understand and speak Italian
- History of cognitive deficits before hospital admission
- Unstable fractures or traumas requiring immobility, mobility restrictions, or bed rest
- Terminally ill patients in palliative care
- Any other clinical reasons that may prevent patient mobilization according to caring physician.
Key Trial Info
Start Date :
June 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07195942
Start Date
June 22 2023
End Date
November 1 2025
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico Humanitas
Pieve Emanuele, Milano, Italy, 20072